Calibrate
Business Services · Colorado, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1601 E 19th Ave Ste 4300, Denver, Colora...Website
www.calibratestudy.orgRevenue
<$5 MillionIndustry
About Calibrate
Calibrate Org Chart
Member Service Representative
Facilitator
Is Calibrate your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Calibrate, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Calibrate recently announced quarterly report
Funding: Get notified immidiatlly once Calibrate has new funding data
Congratulate Masked Content for being promoted to Masked Content at Calibrate
Product Launch: Get notified when Calibrate launches new products
Website visits: Recent activity has been detected on your website
Check if Calibrate has recently received funding, and reach out quickly before it becomes old news!
Click to see if Calibrate had a recent Job posting/layoffs
Check out if Calibrate is spiking on competitors!
Recommended Actions
Find VP level buyers at Calibrate
Find 3 more new buyers
Compare Similar Companies to Calibrate
Compare insights from companies similar to Calibrate, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Calibrate is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Calibrate is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Calibrate.
Calibrate Tech Stack
A closer look at the technologies used by Calibrate
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Calibrate
CALIBRATE is a clinical research study focused on lupus nephritis, testing the safety and efficacy of an investigational drug approach involving rituximab and cyclophosphamide followed by belimumab. The study is designed for individuals aged 18 and older who are living with active proliferative lupus nephritis. It is sponsored by the Immune Toleran... Read More